Hyloris Pharmaceuticals SA (EBR:HYL)

Hyloris Pharmaceuticals Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	23.59	30.41	33.46	50.01	64.4
Short-Term Investments	0.56	0.5	10.47	0.53	0.01
Cash & Short-Term Investments	24.15	30.91	43.93	50.54	64.41
Cash Growth	-21.86%	-29.64%	-13.09%	-21.53%	31317.56%
Accounts Receivable	4.86	3.57	4.13	2.32	0.05
Other Receivables	0.51	0.24	-	-	0.21
Receivables	5.37	3.81	4.13	2.32	0.25
Prepaid Expenses	0.19	0.59	1.75	1.1	1.95
Total Current Assets	29.71	35.31	49.8	53.96	66.61
Property, Plant & Equipment	1.99	2.15	1.06	0.3	0.18
Long-Term Investments	3.75	4.8	4.95	4.53	0.01
Other Intangible Assets	1.76	3.83	1.81	1.85	1.51
Long-Term Accounts Receivable	2.05	1.59	1.31	1.71	-
Long-Term Deferred Charges	2.08	-	1.68	1.09	0.87
Other Long-Term Assets	-	-	0.12	-	-
Total Assets	41.34	47.68	60.73	63.44	69.18
Accounts Payable	3.17	3.2	2.3	2.62	1.6
Accrued Expenses	0.26	0.12	0.07	0.08	0.03
Short-Term Debt	-	-	-	-	0.41
Current Portion of Long-Term Debt	0.05	-	-	8.62	-
Current Portion of Leases	0.28	0.24	0.14	0.07	0.05
Current Income Taxes Payable	-	-	-	0.35	0.05
Current Unearned Revenue	-	0.01	-	-	-
Other Current Liabilities	3.41	3.2	3.26	3.25	0.01
Total Current Liabilities	7.16	6.76	5.77	14.98	2.13
Long-Term Debt	0.05	-	-	-	7.89
Long-Term Leases	1.44	1.51	0.75	0.11	0.11
Other Long-Term Liabilities	0.54	0.34	0.3	0.3	-
Total Liabilities	9.19	8.61	6.82	15.39	10.12
Common Stock	0.14	0.14	0.14	0.13	0.13
Additional Paid-In Capital	121.51	121.51	121.51	103.69	103.69
Retained Earnings	-86.47	-80.76	-65.38	-54.81	-43.23
Comprehensive Income & Other	-3.04	-1.82	-2.36	-0.96	-1.54
Total Common Equity	32.14	39.07	53.91	48.06	59.06
Shareholders' Equity	32.14	39.07	53.91	48.06	59.06
Total Liabilities & Equity	41.34	47.68	60.73	63.44	69.18
Total Debt	1.82	1.75	0.89	8.79	8.45
Net Cash (Debt)	22.34	29.15	43.04	41.75	55.96
Net Cash Growth	-23.39%	-32.27%	3.09%	-25.39%	-
Net Cash Per Share	0.80	1.04	1.58	1.62	2.56
Filing Date Shares Outstanding	28	28	28	25.83	25.83
Total Common Shares Outstanding	28	28	28	25.83	25.83
Working Capital	22.55	28.55	44.03	38.98	64.48
Book Value Per Share	1.15	1.40	1.93	1.86	2.29
Tangible Book Value	30.39	35.24	52.1	46.2	57.55
Tangible Book Value Per Share	1.09	1.26	1.86	1.79	2.23

Updated Oct 16, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.